Literature DB >> 21211838

Feasibility of extended-coverage perfusion and dynamic computer tomography (CT) angiography using toggling-table technique on 64-slice CT.

Jun Horiguchi1, Yoshihiro Kiura, Junpei Tanaka, Hiroshi Fukuda, Masao Kiguchi, Chikako Fujioka, Kaoru Kurisu, Kazuo Awai.   

Abstract

PURPOSE: The major drawbacks of brain computed tomography (CT) perfusion are limited coverage in the z-axis, radiation exposure and the use of contrast medium, all of which increase when CT angiography (CTA) is performed with double acquisitions. The purpose of this study was to investigate the feasibility of the 'toggling-table' technique using a 40-mm detector.
MATERIALS AND METHODS: The clinical usefulness of CT perfusion and 4D-CTA (time-resolved 3D-CTA), as well as the time taken and radiation exposure, were assessed in 14 non-ischemic patients clinically indicated for CT perfusion and CTA.
RESULTS: A perfusion map and 4D-CTA was successfully achieved in all patients. The total time needed for scanning and processing was approximately 30 min per examination. The 80-mm CT perfusion coverage and 4D-CTA images were advantageous for analyses of the anatomy and widely distributed lesions. The estimated effective radiation dose was 2.22 mSv, and the amount of contrast media was 40 mL.
CONCLUSION: The 'toggling-table' technique acts as a 'one-stop-shop' protocol for perfusion mapping and 4D-CTA over a wide area, following a single contrast injection and scan.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21211838     DOI: 10.1016/j.neurad.2010.10.004

Source DB:  PubMed          Journal:  J Neuroradiol        ISSN: 0150-9861            Impact factor:   3.447


  1 in total

1.  Interleaving cerebral CT perfusion with neck CT angiography. Part II: clinical implementation and image quality.

Authors:  Marcel T H Oei; Frederick J A Meijer; Willem-Jan van der Woude; Ewoud J Smit; Bram van Ginneken; Rashindra Manniesing; Mathias Prokop
Journal:  Eur Radiol       Date:  2016-09-21       Impact factor: 5.315

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.